Roberto C. Bolton-Delgado

Logrono, LO, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 128 publications

Building Expertise Across Borders: The IAEA's Expanding Digital Education in Nuclear Medicine and Radiology.

Building Expertise Across Borders: The IAEA's Expanding Digital Education in Nuclear Medicine and Radiology.

Journal: Diagnostics (Basel, Switzerland)

Published: May 21, 2026

Evaluation of the diagnostic efficacy of [18F]FDG PET radiomic analysis for tumor differentiation in patients with non-small cell lung cancer.

Evaluation of the diagnostic efficacy of [18F]FDG PET radiomic analysis for tumor differentiation in patients with non-small cell lung cancer.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: July 08, 2025

Evaluation of the diagnostic efficacy of [18F]FDG PET radiomic analysis for tumor differentiation in patients with non-small cell lung cancer.

Evaluation of the diagnostic efficacy of [18F]FDG PET radiomic analysis for tumor differentiation in patients with non-small cell lung cancer.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: July 08, 2025

Efficacy and Safety of Radioligand Therapy with Actinium-225 DOTATATE in Patients with Advanced, Metastatic or Inoperable Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis.

Efficacy and Safety of Radioligand Therapy with Actinium-225 DOTATATE in Patients with Advanced, Metastatic or Inoperable Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis.

Journal: Medicina (Kaunas, Lithuania)

Published: June 25, 2025

[68Ga]Ga-FAPI-46: an imaging biomarker for FAP-positive tumours.

[68Ga]Ga-FAPI-46: an imaging biomarker for FAP-positive tumours.

Journal: The Lancet. Oncology

Published: June 12, 2025

Fibroblast Activation Protein Inhibitor (FAPI) PET in Sarcoma: An Update and Future Perspective.

Fibroblast Activation Protein Inhibitor (FAPI) PET in Sarcoma: An Update and Future Perspective.

Journal: Seminars in nuclear medicine

Published: April 23, 2025

Comparison of MRI, [ 18 F]FDG-PET/CT, and [ 18 F]FDG-PET/MRI for Initial Staging of Multiple Myeloma : A Systematic Review and Meta-analysis.

Comparison of MRI, [ 18 F]FDG-PET/CT, and [ 18 F]FDG-PET/MRI for Initial Staging of Multiple Myeloma : A Systematic Review and Meta-analysis.

Journal: Clinical nuclear medicine

Published: April 22, 2025

Diagnostic value of dual-tracer PET/CT with [18F]FDG and PSMA ligands in prostate cancer: an updated systematic review.

Diagnostic value of dual-tracer PET/CT with [18F]FDG and PSMA ligands in prostate cancer: an updated systematic review.

Journal: Frontiers in medicine

Published: April 07, 2025

New Targets for Imaging in Nuclear Medicine.

New Targets for Imaging in Nuclear Medicine.

Journal: Seminars in nuclear medicine

Published: March 27, 2025

Whole-body MRI Versus [ 18 F]FDG PET/CT in Diagnosing and Monitoring Plasmacytomas : A Comparative Study.

Whole-body MRI Versus [ 18 F]FDG PET/CT in Diagnosing and Monitoring Plasmacytomas : A Comparative Study.

Journal: Clinical nuclear medicine

Published: March 01, 2025

Lymphoscintigraphy for the Evaluation of Primary Lymphedema: A Scoring System Aimed at Harmonizing the Procedure and Interpretation and Increasing Reproducibility.

Lymphoscintigraphy for the Evaluation of Primary Lymphedema: A Scoring System Aimed at Harmonizing the Procedure and Interpretation and Increasing Reproducibility.

Journal: Clinical nuclear medicine

Published: January 08, 2025

[177Lu]Lu-EDTMP -a bone pain palliating agent: pharmacokinetics, biodistribution, safety profile and clinical evaluation in osseous metastatic patients.

[177Lu]Lu-EDTMP -a bone pain palliating agent: pharmacokinetics, biodistribution, safety profile and clinical evaluation in osseous metastatic patients.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 20, 2024

Showing 1-12 of 128

Last Updated: 09/26/2026